For the other cytokines with nominal mendelian randomisation evidence (<0.05) for coronary artery disease risk, TRAIL also had evidence for colocalisation with coronary artery disease risk (PPshared /(PPshared+PPdistinct) >0.99). The gene discussed is TNFSF10; the disease is coronary artery disorder.